1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Medical Marijuana Market
2.2. Global Medical Marijuana Market, By Application, 2023 (US$ Million)
2.3. Global Medical Marijuana Market, By Point of Sale, 2023 (US$ Million)
2.4. Global Medical Marijuana Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Medical Marijuana Market: Competitive Analysis
3.1. Market Positioning of Key Medical Marijuana Market Vendors
3.2. Strategies Adopted by Medical Marijuana Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Medical Marijuana Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Medical Marijuana Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Chronic Pain
5.3.2. Neurological Disorders
5.3.3. Cancer
5.3.4. Others (Anorexia, Nausea etc.)

6. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Hospital Pharmacy
6.3.2. Dispensaries


7. North America Medical Marijuana Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
7.3. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
7.4.Medical Marijuana Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
7.4.1.1.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
7.4.1.2.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
7.4.1.3.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)

8. UK and European Union Medical Marijuana Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
8.3. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
8.4.Medical Marijuana Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
8.4.1.1.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
8.4.1.2.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
8.4.1.3.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
8.4.1.4.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
8.4.1.5.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
8.4.1.6.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)

9. Asia Pacific Medical Marijuana Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
9.3. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
9.4.Medical Marijuana Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
9.4.1.1.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
9.4.1.2.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
9.4.1.3.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
9.4.1.4.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
9.4.1.5.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
9.4.1.6.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)

10. Latin America Medical Marijuana Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
10.3. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
10.4.Medical Marijuana Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
10.4.1.1.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
10.4.1.2.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
10.4.1.3.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)

11. Middle East and Africa Medical Marijuana Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
11.3. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
11.4.Medical Marijuana Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
11.4.1.1.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
11.4.1.2.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Medical Marijuana Market: By Application, 2022-2032, USD (Million)
11.4.1.3.2. Medical Marijuana Market: By Point of Sale, 2022-2032, USD (Million)

12. Company Profile
12.1. AbbVie, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. CannaGrow Holdings, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Canopy Growth Corporation, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. GW Pharmaceuticals, Plc.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Insys Therapeutics, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Novartis AG
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Lexaria Corporation
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Pfizer, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Teva Pharmaceutical Industries Ltd.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. United Cannabis Corporation
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives